Cancer survivors post-chemotherapy exhibit unique proprioceptive deficits in proximal limbs
Tóm tắt
Oxaliplatin (OX) chemotherapy for colorectal cancer is associated with adverse neurotoxic effects that can contribute to long-term sensorimotor impairments in cancer survivors. It is often thought that the sensorimotor impairments are dominated by OX-induced dying-back sensory neuropathy that primarily affects the distal regions of the limb. Recent preclinical studies have identified encoding dysfunction of muscle proprioceptors as an alternative mechanism. Unlike the dying-back sensory neuropathy affecting distal limbs, dysfunction of muscle proprioceptors could have more widespread effects. Most investigations of chemotherapy-induced sensorimotor impairments have considered only the effects of distal changes in sensory processing; none have evaluated proximal changes or their influence on function. Our study fills this gap by evaluating the functional use of proprioception in the shoulder and elbow joints of cancer survivors post OX chemotherapy. We implemented three multidirectional sensorimotor tasks: force matching, target reaching, and postural stability tasks to evaluate various aspects of proprioception and their use. Force and kinematic data of the sensorimotor tasks were collected in 13 cancer survivors treated with OX and 13 age-matched healthy controls. Cancer survivors exhibited less accuracy and precision than an age-matched control group when they had to rely only on proprioceptive information to match force, even for forces that required only torques about the shoulder. There were also small differences in the ability to maintain arm posture but no significant differences in reaching. The force deficits in cancer survivors were significantly correlated with self-reported motor dysfunction. These results suggest that cancer survivors post OX chemotherapy exhibit proximal proprioceptive deficits, and that the deficits in producing accurate and precise forces are larger than those for producing unloaded movements. Current clinical assessments of chemotherapy-related sensorimotor dysfunction are largely limited to distal symptoms. Our study suggests that we also need to consider changes in proximal function. Force matching tasks similar to those used here could provide a clinically meaningful approach to quantifying OX-related movement dysfunction during and after chemotherapy.
Tài liệu tham khảo
Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343–51.
Chiorazzi A, Semperboni S, Marmiroli P. Current View in platinum drug mechanisms of peripheral neurotoxicity. Toxics. 2015;3(3):304–21.
de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18(16):2938–47.
Noh SH, Park SR, Yang HK, Chung HC, Chung IJ, Kim SW, Kim HH, Choi JH, Kim HK, Yu W, et al. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol. 2014;15(12):1389–96.
Burakgazi AZ, Messersmith W, Vaidya D, Hauer P, Hoke A, Polydefkis M. Longitudinal assessment of oxaliplatin-induced neuropathy. Neurology. 2011;77(10):980–6.
Pachman DR, Qin R, Seisler DK, Smith EM, Beutler AS, Ta LE, Lafky JM, Wagner-Johnston ND, Ruddy KJ, Dakhil S, et al. Clinical course of oxaliplatin-induced neuropathy: results from the randomized phase III trial N08CB (Alliance). J Clin Oncol. 2015;33(30):3416–22.
Argyriou AA, Bruna J, Marmiroli P, Cavaletti G. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol. 2012;82(1):51–77.
Grothey A. Oxaliplatin-safety profile: neurotoxicity. Semin Oncol. 2003;30(4 Suppl 15):5–13.
Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol. 2013;31(21):2699–707.
Wang AB, Housley SN, Flores AM, Kircher SM, Perreault EJ, Cope TC. A review of movement disorders in chemotherapy-induced neurotoxicity. J Neuroeng Rehabil. 2021;18(1):16.
Vincent JA, Wieczerzak KB, Gabriel HM, Nardelli P, Rich MM, Cope TC. A novel path to chronic proprioceptive disability with oxaliplatin: distortion of sensory encoding. Neurobiol Dis. 2016;95:54–65.
Housley SN, Nardelli P, Carrasco DI, Rotterman TM, Pfahl E, Matyunina LV, McDonald JF, Cope TC. Cancer Exacerbates Chemotherapy-Induced Sensory Neuropathy. Cancer Res. 2020;80(13):2940–55.
Housley SN, Nardelli P, Rotterman TM, Cope TC. Neural circuit mechanisms of sensorimotor disability in cancer treatment. Proc Natl Acad Sci U S A. 2021. https://doi.org/10.1073/pnas.2100428118.
Sanes JN, Mauritz KH, Evarts EV, Dalakas MC, Chu A. Motor deficits in patients with large-fiber sensory neuropathy. Proc Natl Acad Sci U S A. 1984;81(3):979–82.
Ghez C, Gordon J, Ghilardi MF. Impairments of reaching movements in patients without proprioception. II. Effects of visual information on accuracy. J Neurophysiol. 1995;73(1):361–72.
Gordon J, Ghilardi MF, Ghez C. Impairments of reaching movements in patients without proprioception. I. Spatial errors. J Neurophysiol. 1995;73(1):347–60.
Cavaletti G, Frigeni B, Lanzani F, Mattavelli L, Susani E, Alberti P, Cortinovis D, Bidoli P. Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools. Eur J Cancer. 2010;46(3):479–94.
Monfort SM, Pan X, Patrick R, Ramaswamy B, Wesolowski R, Naughton MJ, Loprinzi CL, Chaudhari AMW, Lustberg MB. Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients. Breast Cancer Res Treat. 2017;164(1):69–77.
Sanes JN, Shadmehr R. Sense of muscular effort and somesthetic afferent information in humans. Can J Physiol Pharmacol. 1995;73(2):223–33.
Dukelow SP, Herter TM, Moore KD, Demers MJ, Glasgow JI, Bagg SD, Norman KE, Scott SH. Quantitative assessment of limb position sense following stroke. Neurorehabil Neural Repair. 2010;24(2):178–87.
Gurari N, van der Helm NA, Drogos JM, Dewald JPA. Accuracy of individuals post-hemiparetic stroke in matching torques between arms depends on the arm referenced. Front Neurol. 2019;10:921.
Logan LM, Semrau JA, Cluff T, Scott SH, Dukelow SP. Effort matching between arms depends on relative limb geometry and personal control. J Neurophysiol. 2019;121(2):459–70.
Cai NH, Cherepanova P, Gurari N. Impact of abducting at the shoulder on perceiving torques about the elbow. IEEE World Haptics Conference 2021:625–630.
Perreault EJ, Chen K, Trumbower RD, Lewis G. Interactions with compliant loads alter stretch reflex gains but not intermuscular coordination. J Neurophysiol. 2008;99(5):2101–13.
Han J, Waddington G, Adams R, Anson J, Liu Y. Assessing proprioception: A critical review of methods. J Sport Health Sci. 2016;5(1):80–90.
Semrau JA, Herter TM, Scott SH, Dukelow SP. Robotic identification of kinesthetic deficits after stroke. Stroke. 2013;44(12):3414–21.
Zbytniewska M, Kanzler CM, Jordan L, Salzmann C, Liepert J, Lambercy O, Gassert R. Reliable and valid robot-assisted assessments of hand proprioceptive, motor and sensorimotor impairments after stroke. J Neuroeng Rehabil. 2021;18(1):115.
Mussa-Ivaldi FA, Hogan N, Bizzi E. Neural, mechanical, and geometric factors subserving arm posture in humans. J Neurosci. 1985;5(10):2732–43.
Perreault EJ, Kirsch RF, Crago PE. Multijoint dynamics and postural stability of the human arm. Exp Brain Res. 2004;157(4):507–17.
Velasco R, Bruna J, Briani C, Argyriou AA, Cavaletti G, Alberti P, Frigeni B, Cacciavillani M, Lonardi S, Cortinovis D, et al. Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients. J Neurol Neurosurg Psychiatry. 2014;85(4):392–8.
Monfort SM, Pan X, Loprinzi CL, Lustberg MB, Chaudhari AMW. Impaired Postural control and altered sensory organization during quiet stance following neurotoxic chemotherapy: a preliminary study. Integr Cancer Ther. 2019;18:1534735419828823.
Zahiri M, Chen KM, Zhou H, Nguyen H, Workeneh BT, Yellapragada SV, Sada YH, Schwenk M, Najafi B. Using wearables to screen motor performance deterioration because of cancer and chemotherapy-induced peripheral neuropathy (CIPN) in adults - Toward an early diagnosis of CIPN. J Geriatric Oncol. 2019;10(6):960–7.
Kneis S, Wehrle A, Dalin D, Wiesmeier IK, Lambeck J, Gollhofer A, Bertz H, Maurer C. A new approach to characterize postural deficits in chemotherapy-induced peripheral neuropathy and to analyze postural adaptions after an exercise intervention. BMC Neurol. 2020;20(1):23.
Osumi M, Sumitani M, Abe H, Otake Y, Kumagaya SI, Morioka S. Kinematic evaluation for impairment of skilled hand function in chemotherapy-induced peripheral neuropathy. J Hand Ther. 2019;32(1):41–7.
Soveri LM, Lamminmäki A, Hänninen UA, Karhunen M, Bono P, Osterlund P. Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy. Acta Oncol. 2019;58(4):398–406.
Jan Nijhof E, Gabriel DA. Maximum isometric arm forces in the horizontal plane. J Biomech. 2006;39(4):708–16.
Proske U, Allen T. The neural basis of the senses of effort, force and heaviness. Exp Brain Res. 2019;237(3):589–99.
Monjo F, Shemmell J, Forestier N. The sensory origin of the sense of effort is context-dependent. Exp Brain Res 2018, 236(7):1997-2008.
Mccloske.Di, Ebeling P, Goodwin GM. Estimation of weights and tensions and apparent involvement of a sense of effort. Exp Neurol. 1974;42(1):220–32.
Roland PE, Ladegaard-Pedersen H. A quantitative analysis of sensations of tension and of kinaesthesia in man. Evidence for a peripherally originating muscular sense and for a sense of effort. Brain. 1977;100(4):671–92.
Therrien AS, Balasubramaniam R. Timing and visual feedback constraints on repetitive finger force production. Exp Brain Res. 2010;201(4):673–9.
Therrien AS, Richardson BA, Balasubramaniam R. Continuous theta-burst stimulation to primary motor cortex reduces the overproduction of forces following removal of visual feedback. Neuropsychologia. 2011;49(10):2941–6.
Walsh LD, Taylor JL, Gandevia SC. Overestimation of force during matching of externally generated forces. J Physiol. 2011;589(Pt 3):547–57.
Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR. Mechanisms of cancer-related fatigue. Oncologist. 2007;12(Suppl 1):22–34.
Housley SN, Nardelli P, Powers RK, Rich MM, Cope TC. Chronic defects in intraspinal mechanisms of spike encoding by spinal motoneurons following chemotherapy. Exp Neurol. 2020;331:113354.
Rand D. Proprioception deficits in chronic stroke-Upper extremity function and daily living. PLoS ONE. 2018;13(3):e0195043.